Product Images Atropine Sulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Atropine Sulfate NDC 51662-1619 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

POUCH - 51662 1619 2 POUCH LABEL

POUCH - 51662 1619 2 POUCH LABEL

Atropine sulfate injection is a medication used to treat certain types of irregular heartbeats and to reduce salivation and mucus secretion during surgery. It is available in a vial containing 8mg/20mL. The cost is €0.4mg/nL. The dosage should be administered under medical supervision only with a recommended pH of 5.5. The provided code "ioc: 560z 1are 2" and "RXONLY" indicate the storage and prescribing information.*

CASE - 51662 1619 3 CASE LABEL

CASE - 51662 1619 3 CASE LABEL

Atropine sulfate injection is a medication available in a 20mL vial containing 8ng/20nL (or €0.4ng/mL) of the injection. This comes in a case of 10 vials meant for medical use only and requires a prescription (Rx Only). The remaining characters such as "Vo s1eez" and "16193" are not readable and do not provide useful information.*

RFID - 51662 1619 3 SERIALIZED RFID LABEL

RFID - 51662 1619 3 SERIALIZED RFID LABEL

D1 - D 1

D1 - D 1

D INTER - DRUG INTER

D INTER - DRUG INTER

Atropine Sulfate Injection was found to slow down the absorption of mexiletine but did not affect its oral bioavailability. The combination of atropine and intravenous metoclopramide during pre-anesthesia treatment reversed the delayed absorption of mexiletine.*

STRUCTURE - STRUCTURE

STRUCTURE - STRUCTURE

Not available. It seems to be a combination of mathematical symbols that do not form a coherent description.*

SPECIFIC POP - USE IN SPECIFIC

SPECIFIC POP - USE IN SPECIFIC

Atropine Sulfate Injection is a medication whose safety for pregnant women is not yet confirmed due to limited available data. Without proper medical attention, there are associated risks to the mother and fetus from severe or life-threatening muscarinic events. Furthermore, there are no animal reproduction studies to inform the safety of this medication for pregnant women.*

VIAL - VIAL LABEL

VIAL - VIAL LABEL

This is a description of a medication with the NDC code 0641-6251-01 containing Atropine sulfate. It is intended for injection through various routes such as Intravenous, Intramuscular, Subcutaneous, Intraosseous, or Endofracheal use. The medication comes in a 20ml multi-dose vial and should be stored at 25°C and discarded within 24 hours. The manufacturer is Hikma and the address is mentioned as Berely Helghts, W 0722.*

D2 - d 2

D2 - d 2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.